High price and demand for semaglutide means lack of access for US patients

BMJ. 2023 Aug 30:382:1863. doi: 10.1136/bmj.p1863.
No abstract available

MeSH terms

  • Glucagon-Like Peptides* / therapeutic use
  • Humans
  • Patients*

Substances

  • semaglutide
  • Glucagon-Like Peptides